{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:10:29Z","timestamp":1790302229390,"version":"4.1.0"},"reference-count":157,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Inflammatory bowel diseases (IBD), including Crohn\u00b4s disease (CD) and ulcerative colitis (UC) remain highly prevalent and are associated with a reduced quality of life in affected patients. The pathophysiology of IBD is multifactorial since genetic predisposition, altered immune function, changes in intestinal microbiota, environmental factors, and loss of intestinal barrier function together induce disease manifestation. A critical key factor is the dysregulation of the immune system which explains that all medical therapeutic approaches target the immune response. However, the success of these therapies is limited and associated with severe side effects which demonstrates the need for novel therapeutic approaches. Previous research demonstrated that CD4+ regulatory T (Treg) cells are important regulators of intestinal homeostasis but are reduced in number and function relative to effector T cells in IBD. This led to the concept that genetically engineered, antigen-specific Tregs may represent a promising strategy to address immune dysregulation in IBD. Due to their antigen specificity, chimeric antigen receptors (CARs) enable additional target-dependent activation and migration of Tregs at disease sites. While CARs are increasingly established for the generation of antigen-specificity for T cell therapies in cancer, the implementation of CARs for IBD is in a preliminary state. Nonetheless, CAR constructs specific to circulating carcinoembryonic antigen (CEA), flagellin, or IL23R have been developed recently for potential application in IBD. Based on these novel developments, this review will discuss the role of Tregs in IBD disorders and present the current state of CAR Treg models.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1667053","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:30:28Z","timestamp":1761715828000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Opportunities and challenges harnessing antigen-specific CD4+ regulatory T cells in inflammatory bowel disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Jessica","family":"K\u00fcmmel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna C.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B3","article-title":"Crohn Disease","volume-title":"StatPearls","author":"Ranasinghe","year":"2025"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.3390\/jcm12206450","article-title":"Oral manifestations of crohn\u2019s disease: A systematic review","volume":"12","author":"Pecci-Lloret","year":"2023","journal-title":"J Clin Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e17187","DOI":"10.7759\/cureus.17187","article-title":"Extra-intestinal manifestations of inflammatory bowel disease","volume":"13","author":"Sange","year":"2021","journal-title":"Cureus"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.04.010","article-title":"Crohn disease: epidemiology, diagnosis, and management","volume":"92","author":"Feuerstein","year":"2017","journal-title":"Mayo Clinic Proc"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third european evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J Crohn\u2019s Colitis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.01.018","article-title":"Ulcerative colitis","volume":"94","author":"Feuerstein","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100851","DOI":"10.1016\/j.disamonth.2019.02.004","article-title":"A comprehensive review and update on ulcerative colitis","volume":"65","author":"Gajendran","year":"2019","journal-title":"Disease-a-Month"},{"key":"B10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1001\/jamapediatrics.2017.2571","article-title":"The role of environmental factors in the pathogenesis of inflammatory bowel diseases: A review","volume":"171","author":"Shouval","year":"2017","journal-title":"JAMA Pediatr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.09.013","article-title":"Mechanisms of disease: inflammatory bowel diseases","volume":"94","author":"Ramos","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7247238","DOI":"10.1155\/2019\/7247238","article-title":"A comprehensive review and update on the pathogenesis of inflammatory bowel disease","volume":"2019","author":"Guan","year":"2019","journal-title":"J Immunol Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-025-03974-2","article-title":"Microbiota interaction with Tregs: a target for colitis","author":"Mortezaee","year":"2025","journal-title":"Clin Trans Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa9420","article-title":"Individual intestinal symbionts induce a distinct population of RORy+ regulatory T cells","volume":"349","author":"Sefik","year":"2015","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.8.4937","article-title":"Intestinal lamina propria retaining CD4+CD25+ Regulatory T cells is A suppressive site of intestinal inflammation1","volume":"178","author":"Makita","year":"2007","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/gutjnl-2024-332919","article-title":"Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet","volume":"74","author":"Neurath","year":"2024","journal-title":"Gut"},{"key":"B17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/biomedicines10020287","article-title":"CAR-T regulatory (CAR-Treg) cells: engineering and applications","volume":"10","author":"Arjomandnejad","year":"2022","journal-title":"Biomedicines"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01608","article-title":"The future of regulatory T cell therapy: promises and challenges of implementing CAR technology","volume":"11","author":"Mohseni","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in Treg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.03.043","article-title":"Peripheral and intestinal regulatory CD4+CD25high T cells in inflammatory bowel disease","volume":"128","author":"Maul","year":"2005","journal-title":"Gastroenterology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.06.019","article-title":"Exacerbated intestinal inflammation in P2Y6 deficient mice is associated with Th17 activation","volume":"1865","author":"Salem","year":"2019","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0309203","article-title":"Hyperactivated B cells in human inflammatory bowel disease","volume":"86","author":"Noronha","year":"2009","journal-title":"J Leukoc Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200505000-00012","article-title":"Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome","volume":"17","author":"Raddatz","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri.2016.36","article-title":"Development and maintenance of intestinal regulatory T cells","volume":"16","author":"Tanoue","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1053\/j.gastro.2024.01.007","article-title":"The FOXP3(+) pro-inflammatory T cell: A potential therapeutic target in crohn\u2019s disease","volume":"166","author":"Kosinsky","year":"2024","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.04.006","article-title":"Regulatory T cell identity: formation and maintenance","volume":"36","author":"Li","year":"2015","journal-title":"Trends Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ni1160","article-title":"CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2","volume":"6","author":"Tai","year":"2005","journal-title":"Nat Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.9.5317","article-title":"Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance","volume":"162","author":"Itoh","year":"1999","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.4049\/jimmunol.179.2.1390-b","article-title":"A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-\u03b2","volume":"179","author":"Selvaraj","year":"2007","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00125","article-title":"Critical role of TGF-\u03b2 and IL-2 receptor signaling in foxp3 induction by an inhibitor of DNA methylation","volume":"9","author":"Freudenberg","year":"2018","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.03.002","article-title":"Development and maintenance of regulatory T cells","volume":"38","author":"Ohkura","year":"2013","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1321228","article-title":"Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity","volume":"14","author":"Santosh Nirmala","year":"2023","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4771","article-title":"Helios, and not FoxP3, is the marker of activated Tregs expressing GARP\/LAP","volume":"6","author":"Elkord","year":"2015","journal-title":"Oncotarget"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2010.02.001","article-title":"A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells","volume":"47","author":"Getnet","year":"2010","journal-title":"Mol Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.immuni.2004.09.002","article-title":"Human T regulatory cells can use the perforin pathway to cause autologous target cell death","volume":"21","author":"Grossman","year":"2004","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.04.015","article-title":"Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation","volume":"25","author":"Mempel","year":"2006","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00378","article-title":"Mechanisms underlying CD4+ Treg immune regulation in the adult: from experiments to models","volume":"4","author":"Caridade","year":"2013","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0472","article-title":"A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment","volume":"13","author":"Strauss","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221676","article-title":"Regulatory T cells suppress CD4+ effector T cell activation by controlling protein synthesis","volume":"220","author":"So","year":"2023","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.4.1783","article-title":"Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism","volume":"174","author":"Gondek","year":"2005","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00216","article-title":"Regulatory T-cell-mediated suppression of conventional T-cells and dendritic cells by different cAMP intracellular pathways","volume":"7","author":"Rueda","year":"2016","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737781","article-title":"Modulation of murine dendritic cell function by adenine nucleotides and adenosine: involvement of the A(2B) receptor","volume":"38","author":"Ben Addi","year":"2008","journal-title":"Eur J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J Exp Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e4217","DOI":"10.21769\/BioProtoc.4217","article-title":"Suppression of human dendritic cells by regulatory T cells","volume":"11","author":"Huang","year":"2021","journal-title":"Bio Protoc"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nri3108","article-title":"The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses","volume":"11","author":"Walker","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/eji.202048746","article-title":"Cross talk between human regulatory T cells and antigen-presenting cells: Lessons for clinical applications","volume":"51","author":"Wardell","year":"2021","journal-title":"Eur J Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.7.4184","article-title":"Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells","volume":"178","author":"Bayry","year":"2007","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.9.5916","article-title":"Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II","volume":"180","author":"Liang","year":"2008","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.08.046","article-title":"Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice","volume":"116","author":"Lin","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i7.2195","article-title":"Role of regulatory T cell in the pathogenesis of inflammatory bowel disease","volume":"22","author":"Yamada","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/BF02212697","article-title":"Soluble interleukin-2 receptor in Crohn\u2019s disease","volume":"40","author":"Louis","year":"1995","journal-title":"Digestive Dis Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"109824","DOI":"10.1016\/j.intimp.2023.109824","article-title":"Blood regulatory T cells in inflammatory bowel disease, a systematic review, and meta-analysis","volume":"117","author":"Jalalvand","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"108515","DOI":"10.1016\/j.clim.2020.108515","article-title":"The IL-2 \u2013 IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor","volume":"218","author":"Damoiseaux","year":"2020","journal-title":"Clin Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/BF02065412","article-title":"Interleukin-2 receptor \u03b1 and \u03b2 chain expression by circulating \u03b1\u03b2 and \u03b3\u03b4 T cells in inflammatory bowel disease","volume":"40","author":"Kirman","year":"1995","journal-title":"Digestive Dis Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090746","article-title":"Feedback control of regulatory T cell homeostasis by dendritic cells in vivo","volume":"206","author":"Darrasse-Jeze","year":"2009","journal-title":"J Exp Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041982","article-title":"Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization","volume":"201","author":"Setoguchi","year":"2005","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ Immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2007.02.005","article-title":"Thymic development and peripheral homeostasis of regulatory T cells","volume":"19","author":"Liston","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e328311f26e","article-title":"Regulatory T cells in inflammatory bowel disease","volume":"24","author":"Boden","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21229","article-title":"Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab","volume":"16","author":"Li","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.551887","article-title":"Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn\u2019s disease patients","volume":"46","author":"Reikvam","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1053\/j.gastro.2008.12.053","article-title":"Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression","volume":"136","author":"Fantini","year":"2009","journal-title":"Gastroenterology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318281f5a3","article-title":"Induced and natural regulatory T cells in the development of inflammatory bowel disease","volume":"19","author":"Mayne","year":"2013","journal-title":"Inflammation Bowel Dis"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.03.018","article-title":"Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation","volume":"34","author":"Chaudhry","year":"2011","journal-title":"Immunity"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1038\/s41467-020-15695-x","article-title":"Cytokines regulate the antigen-presenting characteristics of human circulating and tissue-resident intestinal ILCs","volume":"11","author":"Rao","year":"2020","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21590","article-title":"Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn\u2019s disease","volume":"17","author":"Ng","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.154.5.2434","article-title":"Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation","volume":"154","author":"Casini-Raggi","year":"1995","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033402","article-title":"Anti-interleukin-12 antibody for active Crohn\u2019s disease","volume":"351","author":"Mannon","year":"2004","journal-title":"N Engl J Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2009.03053.x","article-title":"Regulatory T cells overturned: the effectors fight back","volume":"126","author":"Walker","year":"2009","journal-title":"Immunology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"B80","article-title":"Generation of effector T cells expressing chimeric T cell receptor with antibody type-specificity","volume":"21","author":"Gross","year":"1989","journal-title":"Transplant Proc"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.24.10024","article-title":"Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity","volume":"86","author":"Gross","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25418","article-title":"An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer","volume":"94","author":"Feins","year":"2019","journal-title":"Am J Hematol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1034707","article-title":"Next generations of CAR-T cells - new therapeutic opportunities in hematology","volume":"13","author":"Tomasik","year":"2022","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-021-09236-x","article-title":"Chimeric antigen receptor (CAR) immunotherapy: basic principles, current advances, and future prospects in neuro-oncology","volume":"69","author":"Yoo","year":"2021","journal-title":"Immunol Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/ijms20061283","article-title":"Killing mechanisms of chimeric antigen receptor (CAR) T cells","volume":"20","author":"Benmebarek","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/6.8.989","article-title":"An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability","volume":"6","author":"Whitlow","year":"1993","journal-title":"Protein Eng"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2018.12.009","article-title":"Engineering and design of chimeric antigen receptors","volume":"12","author":"Guedan","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/01.cji.0000161397.96582.59","article-title":"The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens","volume":"28","author":"Guest","year":"2005","journal-title":"J Immunother"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901766","article-title":"The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3\u03b6 Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR\/CD3 Complex","volume":"184","author":"Bridgeman","year":"2010","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.2.720","article-title":"Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors","volume":"90","author":"Eshhar","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0813101106","article-title":"Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains","volume":"106","author":"Carpenito","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Discov"},{"key":"B93","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrd4597","article-title":"The pharmacology of second-generation chimeric antigen receptors","volume":"14","author":"van der Stegen","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96976","article-title":"Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation","volume":"3","author":"Guedan","year":"2018","journal-title":"JCI Insight"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0426","article-title":"A phase I\/IIa trial using CD19-targeted third-generation CAR T cells for lymphoma and leukemia","volume":"24","author":"Enblad","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.210","article-title":"Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase\/AKT\/Bcl-XL activation and CD8+ T cell-mediated tumor eradication","volume":"18","author":"Zhong","year":"2010","journal-title":"Mol Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2015.1046430","article-title":"TRUCKs: the fourth generation of CARs","volume":"15","author":"Chmielewski","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.839783","article-title":"GMP-compliant manufacturing of TRUCKs: CAR T cells targeting GD(2) and releasing inducible IL-18","volume":"13","author":"Glienke","year":"2022","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41416-018-0325-1","article-title":"Teaching an old dog new tricks: next-generation CAR T cells","volume":"120","author":"Tokarew","year":"2019","journal-title":"Br J Cancer"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0103","article-title":"IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression","volume":"71","author":"Chmielewski","year":"2011","journal-title":"Cancer Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci Transl Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01125","article-title":"Chimeric antigen receptor-redirected regulatory T cells suppress experimental allergic airway inflammation, a model of asthma","volume":"8","author":"Skuljec","year":"2017","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1207108","article-title":"Regulatory T cells targeting a pathogenic MHC class II: Insulin peptide epitope postpone spontaneous autoimmune diabetes","volume":"14","author":"Obarorakpor","year":"2023","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1172\/JCI168601","article-title":"Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice","volume":"133","author":"Spanier","year":"2023","journal-title":"J Clin Invest"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2014.41","article-title":"Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells","volume":"22","author":"Blat","year":"2014","journal-title":"Mol Ther"},{"key":"B106","doi-asserted-by":"publisher","first-page":"102961","DOI":"10.1016\/j.jaut.2022.102961","article-title":"Flagellin-specific human CAR Tregs for immune regulation in IBD","volume":"134","author":"Boardman","year":"2023","journal-title":"J Autoimmun"},{"key":"B107","doi-asserted-by":"publisher","first-page":"jjae135","DOI":"10.1093\/ecco-jcc\/jjae135","article-title":"IL23R-specific CAR Tregs for the treatment of Crohn\u2019s disease","volume":"19","author":"Cui","year":"2024","journal-title":"J Crohns Colitis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3390\/cells12162115","article-title":"Development of beta-amyloid-specific CAR-tregs for the treatment of alzheimer\u2019s disease","volume":"12","author":"Saetzler","year":"2023","journal-title":"Cells"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J Clin Invest"},{"key":"B110","doi-asserted-by":"publisher","first-page":"103057","DOI":"10.1016\/j.jaut.2023.103057","article-title":"Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application","volume":"138","author":"Henschel","year":"2023","journal-title":"J Autoimmun"},{"key":"B111","volume-title":"Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation","year":"2024"},{"key":"B112","volume-title":"Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients (STEADFAST)","year":"2021"},{"key":"B113","volume-title":"Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients (LIBERATE)","year":"2022"},{"key":"B114","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ard.2025.05.431","article-title":"POS0034 REGULATE-RA: A phase 1 study of CAR-T regulatory cells targeting citrullinated proteins in refractory rheumatoid arthritis: interim safety and tolerability","volume":"84","author":"Baxter","year":"2025","journal-title":"Ann Rheumatic Diseases"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1136\/gut.14.11.880","article-title":"Circulating carcinoembryonic antigen (CEA): relationship to clinical status of patients with inflammatory bowel disease","volume":"14","author":"Rule","year":"1973","journal-title":"Gut"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2004.03.009","article-title":"Novel mouse model for carcinoembryonic antigen-based therapy","volume":"9","author":"Chan","year":"2004","journal-title":"Mol Ther"},{"key":"B117","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1006\/scbi.1998.0119","article-title":"The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and Malignant tissues","volume":"9","author":"Hammarstr\u00f6m","year":"1999","journal-title":"Semin Cancer Biol"},{"key":"B118","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1201\/9781482283402","volume-title":"Cell Adhesion and Communication Mediated by the CEA Family (1st ed.)","author":"Stanners","year":"1998"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2008.02939.x","article-title":"The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease","volume":"125","author":"Himmel","year":"2008","journal-title":"Immunology"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20295","article-title":"Bacterial flagellin is a dominant antigen in Crohn disease","volume":"113","author":"Lodes","year":"2004","journal-title":"J Clin Invest"},{"key":"B121","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1053\/j.gastro.2021.03.064","article-title":"Human microbiota flagellins drive adaptive immune responses in crohn\u2019s disease","volume":"161","author":"Alexander","year":"2021","journal-title":"Gastroenterology"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.3.1551","article-title":"Direct stimulation of human T cells via TLR5 and TLR7\/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells","volume":"175","author":"Caron","year":"2005","journal-title":"J Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0502174102","article-title":"Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation","volume":"102","author":"Rhee","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.12.8051","article-title":"Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells","volume":"175","author":"Crellin","year":"2005","journal-title":"J Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1172\/JCI21404","article-title":"IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6","volume":"116","author":"Yen","year":"2006","journal-title":"J Clin Invest"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0415-0","article-title":"Targeting immune cell circuits and trafficking in inflammatory bowel disease","volume":"20","author":"Neurath","year":"2019","journal-title":"Nat Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.08.010","article-title":"Interleukin-23 drives intestinal inflammation through direct activity on T cells","volume":"33","author":"Ahern","year":"2010","journal-title":"Immunity"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0123","article-title":"Soluble carcinoembryonic antigen activates endothelial cells and tumor angiogenesis","volume":"73","author":"Bramswig","year":"2013","journal-title":"Cancer Res"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.655960","article-title":"Regulation of CEACAM family members by IBD-associated triggers in intestinal epithelial cells, their correlation to inflammation and relevance to IBD pathogenesis","volume":"12","author":"Saiz-Gonzalo","year":"2021","journal-title":"Front Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"7616","DOI":"10.1038\/s41598-023-34855-9","article-title":"Clinical implication of tissue carcinoembryonic antigen expression in association with serum carcinoembryonic antigen in colorectal cancer","volume":"13","author":"Aldilaijan","year":"2023","journal-title":"Sci Rep"},{"key":"B132","doi-asserted-by":"publisher","first-page":"16251","DOI":"10.1038\/s41598-024-66780-w","article-title":"Integrating plasma proteomics with genome-wide association data to identify novel drug targets for inflammatory bowel disease","volume":"14","author":"Bai","year":"2024","journal-title":"Sci Rep"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001246","article-title":"Genetic and transcriptomic bases of intestinal epithelial barrier dysfunction in inflammatory bowel disease","volume":"23","author":"Vancamelbeke","year":"2017","journal-title":"Inflammation Bowel Dis"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12172","article-title":"Treg functional stability and its responsiveness to the microenvironment","volume":"259","author":"Barbi","year":"2014","journal-title":"Immunol Rev"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838904","article-title":"Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation","volume":"39","author":"Hoffmann","year":"2009","journal-title":"Eur J Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"83ra41","DOI":"10.1126\/scitranslmed.3001809","article-title":"Massive ex vivo expansion of human natural regulatory T cells (Tregs) with minimal loss of in vivo functional activity","volume":"3","author":"Hippen","year":"2011","journal-title":"Sci Trans Med"},{"key":"B137","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ajt.13456","article-title":"Discarded human thymus is a novel source of stable and long-lived therapeutic regulatory T cells","volume":"16","author":"Dijke","year":"2016","journal-title":"Am J Transplantation"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0232-6","article-title":"T(reg) cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.01.007","article-title":"The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation","volume":"42","author":"DuPage","year":"2015","journal-title":"Immunity"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.325332","article-title":"Polycomb antagonizes p300\/CREB-binding protein-associated factor to silence FOXP3 in a Kruppel-like factor-dependent manner","volume":"287","author":"Xiong","year":"2012","journal-title":"J Biol Chem"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10914","article-title":"Combination of IL-2, rapamycin, DNA methyltransferase and histone deacetylase inhibitors for the expansion of human regulatory T cells","volume":"8","author":"Miyara","year":"2017","journal-title":"Oncotarget"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxx060","article-title":"Generation of allo-antigen-specific induced Treg stabilized by vitamin C treatment and its application for prevention of acute graft versus host disease model","volume":"29","author":"Kasahara","year":"2017","journal-title":"Int Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2009.05.007","article-title":"Plasticity of CD4+ FoxP3+ T cells","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1126\/science.1191996","article-title":"Stability of the regulatory T cell lineage in vivo","volume":"329","author":"Rubtsov","year":"2010","journal-title":"Science"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0811556106","article-title":"Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity","volume":"106","author":"Komatsu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat Med"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2219086120","article-title":"Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion","volume":"120","author":"Lamarche","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-545020","article-title":"A highly compact epitope-based marker\/suicide gene for easier and safer T-cell therapy","volume":"124","author":"Philip","year":"2014","journal-title":"Blood"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-337360","article-title":"A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells","volume":"118","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00235","article-title":"The inducible caspase-9 suicide gene system as a \u201csafety switch\u201d to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells","volume":"5","author":"Gargett","year":"2014","journal-title":"Front Pharmacol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5907","article-title":"The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on\/off switch for CAR T cells","volume":"11","author":"Mestermann","year":"2019","journal-title":"Sci Transl Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.744763","article-title":"Polyclonal regulatory T cell manufacturing under cGMP: A decade of experience","volume":"12","author":"Balcerek","year":"2021","journal-title":"Front Immunol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001192","article-title":"Characterization and expansion of autologous GMP-ready regulatory T cells for TREG-based cell therapy in patients with ulcerative colitis","volume":"23","author":"Voskens","year":"2017","journal-title":"Inflammatory Bowel Diseases"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0051-2","article-title":"\u2018Off-the-shelf\u2019 allogeneic CAR T cells: development and challenges","volume":"19","author":"Depil","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2012.07.014","article-title":"Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types","volume":"11","author":"Taylor","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/nature21405","article-title":"Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection","volume":"543","author":"Eyquem","year":"2017","journal-title":"Nature"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99442","article-title":"TCR\u03b1\u03b2\/CD3 disruption enables CD3-specific antileukemic T cell immunotherapy","volume":"3","author":"Rasaiyaah","year":"2018","journal-title":"JCI Insight"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1667053\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:30:30Z","timestamp":1761715830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1667053\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":157,"alternative-id":["10.3389\/fimmu.2025.1667053"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1667053","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"article-number":"1667053"}}